Volitionrx (VNRX) Payables (2011 - 2025)

Volitionrx's Payables history runs 11 years deep, the most recent figure standing at $5.3 million for Q4 2025.

• Quarterly Payables rose 92.94% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (up 92.94% YoY) and the FY2025 annual result came in at $5.3 million, up 92.94% from the prior year.
• Payables was $5.3 million for Q4 2025 at Volitionrx, up from $3.4 million in the prior quarter.
• Across five years, Payables topped out at $5.3 million in Q4 2025 and bottomed at $1.1 million in Q2 2021.
• A 5-year average of $2.8 million and a median of $3.0 million in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables jumped 140.24% — and 2025, when it declined 24.8%.
• Volitionrx's Payables stood at $1.5 million in 2021, then surged by 97.28% to $3.0 million in 2022, then advanced by 5.53% to $3.2 million in 2023, then dropped by 13.86% to $2.8 million in 2024, then soared by 92.94% to $5.3 million in 2025.
• Business Quant data shows VNRX's Payables at $5.3 million in Q4 2025, $3.4 million in Q3 2025, and $2.5 million in Q2 2025.